- Home
- SOLSV vs HALO Comparison
SOLSV vs HALO Comparison
Compare SOLSV & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOLSV
- HALO
- Stock Information
- Founded
- SOLSV N/A
- HALO 1998
- Country
- SOLSV United States
- HALO United States
- Employees
- SOLSV N/A
- HALO N/A
- Industry
- SOLSV Aerospace
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOLSV Industrials
- HALO Health Care
- Exchange
- SOLSV Nasdaq
- HALO Nasdaq
- Market Cap
- SOLSV 7.3B
- HALO 7.6B
- IPO Year
- SOLSV N/A
- HALO N/A
- Fundamental
- Price
- SOLSV $49.25
- HALO $65.19
- Analyst Decision
- SOLSV
- HALO Buy
- Analyst Count
- SOLSV 0
- HALO 11
- Target Price
- SOLSV N/A
- HALO $73.18
- AVG Volume (30 Days)
- SOLSV N/A
- HALO 1.7M
- Earning Date
- SOLSV N/A
- HALO 11-03-2025
- Dividend Yield
- SOLSV N/A
- HALO N/A
- EPS Growth
- SOLSV N/A
- HALO 68.93
- EPS
- SOLSV N/A
- HALO 4.37
- Revenue
- SOLSV N/A
- HALO $1,178,672,000.00
- Revenue This Year
- SOLSV N/A
- HALO $32.47
- Revenue Next Year
- SOLSV N/A
- HALO $24.01
- P/E Ratio
- SOLSV N/A
- HALO $14.93
- Revenue Growth
- SOLSV N/A
- HALO 34.97
- 52 Week Low
- SOLSV N/A
- HALO $42.01
- 52 Week High
- SOLSV N/A
- HALO $79.50
- Technical
- Relative Strength Index (RSI)
- SOLSV N/A
- HALO 38.07
- Support Level
- SOLSV N/A
- HALO $64.55
- Resistance Level
- SOLSV N/A
- HALO $66.97
- Average True Range (ATR)
- SOLSV 0.00
- HALO 1.72
- MACD
- SOLSV 0.00
- HALO -0.03
- Stochastic Oscillator
- SOLSV 0.00
- HALO 31.46
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.